NEW biotech ETFs (at least to me). I came across this today reading the BIIB news. I'm not sure why BIIB was in the ophthalmology ETF. I'm not sure how accurate the titles are (e.g. MEDX in the Pulm fund). Nevertheless, looks like a good way to diversify risk in the biotech sector while gaining exposure to small/mid cap biotechs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.